Table 1.

The Demographics and the Clinical Characteristics of the Patients

	Total Patients (n = 17)	fQRS Group (n = 9)	Non‐fQRS Group (n = 8)	P Value
Age (mean ± SD)	52 ± 11 years	53 ± 11	48 ± 11	0.22
Male	9 (53%)	4 (44%)	5 (63%)	0.39
Hypertension	4 (24%)	1 (11%)	3 (38%)	0.24
Diabetes	5 (30%)	2 (22%)	3 (38%)	0.44
Dyslipidemia	3 (18%)	2 (22%)	1 (13%)	0.55
Known CAD	3 (18%)	2 (22%)	1 (13%)	0.55
Heart failure	4 (24%)	3 (33%)	1 (13%)	0.33
Beta‐blockers	4 (24%)	3 (33%)	1 (13%)	0.33
ACEI/ARB	2 (12%)	1 (11%)	1 (13%)	0.74
Aspirin	7 (41%)	4 (44%)	3 (38%)	0.58
Clopidogrel	3 (18%)	2 (22%)	1 (13%)	0.54
Statin	4 (24%)	2 (22%)	2 (25%)	0.67
Ejection fraction (mean ± SD)	54 ± 12	52 ± 12	55 ± 12	0.59
Abnormal GDE	7 (41%)	7 (78%)	0 (0%)	0.002
Bundle branch block	4 (24%)	2 (22%)	2 (25%)	0.66

ACEI = angiotensin converting enzyme inhibitor; ARB = angiotensin receptor blocker; fQRS = fragmented QRS complexes; GDE = gadolinium delayed enhancement.